Palantir Technologies lifts guidance after Q2 results beat Wall Street estimates
Investing.com - Avepoint (NASDAQ: AVPT) reported second quarter EPS of $-0.07, $0.09 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $78M versus the consensus estimate of $75.17M.
Guidance
Avepoint sees Q3 2024 revenue of $82.00M-$84.00M versus the analyst consensus of $82.68M.
Avepoint's stock price closed at $10.17. It is up 24.79% in the last 3 months and up 76.56% in the last 12 months.
Avepoint saw 2 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Avepoint's stock price’s past reactions to earnings here.
According to InvestingPro, Avepoint's Financial Health score is "good performance".
Check out Avepoint's recent earnings performance, and Avepoint's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar